From October 25, 2022 to December 31, 2022, the company has repurchased 2,410,800 shares, representing 0.37% for CNY 50 million. With this, the company has completed the repurchase of 2,410,800 shares, representing 0.37% for CNY 50 million under the buyback announced on October 26, 2022.
Guangdong Hybribio Biotech Co.,Ltd.
Equities
300639
CNE100002N51
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.76 CNY | -0.63% | +1.06% | -49.04% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.04% | 422M | |
-4.72% | 12.35B | |
+99.06% | 8.55B | |
-22.10% | 6.6B | |
+8.48% | 5.88B | |
-22.96% | 3.52B | |
+6.08% | 2.55B | |
+38.04% | 2.39B | |
-7.04% | 2.33B | |
-68.75% | 2.09B |
- Stock Market
- Equities
- 300639 Stock
- News Guangdong Hybribio Biotech Co.,Ltd.
- Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on October 26, 2022.